Waters Revenue 2010-2024 | WAT
Waters annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Waters revenue for the quarter ending September 30, 2024 was $0.740B, a 4.02% increase year-over-year.
- Waters revenue for the twelve months ending September 30, 2024 was $2.905B, a 3.01% decline year-over-year.
- Waters annual revenue for 2023 was $2.956B, a 0.52% decline from 2022.
- Waters annual revenue for 2022 was $2.972B, a 6.68% increase from 2021.
- Waters annual revenue for 2021 was $2.786B, a 17.78% increase from 2020.
| Waters Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $2,956 |
| 2022 | $2,972 |
| 2021 | $2,786 |
| 2020 | $2,365 |
| 2019 | $2,407 |
| 2018 | $2,420 |
| 2017 | $2,309 |
| 2016 | $2,167 |
| 2015 | $2,042 |
| 2014 | $1,989 |
| 2013 | $1,904 |
| 2012 | $1,844 |
| 2011 | $1,851 |
| 2010 | $1,643 |
| 2009 | $1,499 |
| Waters Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $740 |
| 2024-06-30 | $709 |
| 2024-03-31 | $637 |
| 2023-12-31 | $819 |
| 2023-09-30 | $712 |
| 2023-06-30 | $741 |
| 2023-03-31 | $685 |
| 2022-12-31 | $859 |
| 2022-09-30 | $709 |
| 2022-06-30 | $714 |
| 2022-03-31 | $691 |
| 2021-12-31 | $836 |
| 2021-09-30 | $659 |
| 2021-06-30 | $682 |
| 2021-03-31 | $609 |
| 2020-12-31 | $787 |
| 2020-09-30 | $594 |
| 2020-06-30 | $520 |
| 2020-03-31 | $465 |
| 2019-12-31 | $716 |
| 2019-09-30 | $577 |
| 2019-06-30 | $599 |
| 2019-03-31 | $514 |
| 2018-12-31 | $715 |
| 2018-09-30 | $578 |
| 2018-06-30 | $596 |
| 2018-03-31 | $531 |
| 2017-12-31 | $687 |
| 2017-09-30 | $566 |
| 2017-06-30 | $558 |
| 2017-03-31 | $498 |
| 2016-12-31 | $629 |
| 2016-09-30 | $527 |
| 2016-06-30 | $537 |
| 2016-03-31 | $475 |
| 2015-12-31 | $587 |
| 2015-09-30 | $501 |
| 2015-06-30 | $495 |
| 2015-03-31 | $460 |
| 2014-12-31 | $584 |
| 2014-09-30 | $493 |
| 2014-06-30 | $482 |
| 2014-03-31 | $431 |
| 2013-12-31 | $565 |
| 2013-09-30 | $457 |
| 2013-06-30 | $451 |
| 2013-03-31 | $430 |
| 2012-12-31 | $522 |
| 2012-09-30 | $450 |
| 2012-06-30 | $451 |
| 2012-03-31 | $420 |
| 2011-12-31 | $521 |
| 2011-09-30 | $455 |
| 2011-06-30 | $448 |
| 2011-03-31 | $428 |
| 2010-12-31 | $484 |
| 2010-09-30 | $401 |
| 2010-06-30 | $391 |
| 2010-03-31 | $368 |
| 2009-12-31 | $429 |
| 2009-09-30 | $374 |
| 2009-06-30 | $363 |
| 2009-03-31 | $333 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.876B | $2.956B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.393B | 24.93 |
| Intuitive Surgical (ISRG) | United States | $193.619B | 101.23 |
| Edwards Lifesciences (EW) | United States | $43.533B | 27.64 |
| Alcon (ALC) | Switzerland | $42.700B | 28.57 |
| IQVIA Holdings (IQV) | United States | $36.494B | 20.11 |
| IDEXX Laboratories (IDXX) | United States | $35.790B | 42.15 |
| DexCom (DXCM) | United States | $31.431B | 47.33 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.760B | 0.00 |
| Hologic (HOLX) | United States | $17.141B | 18.51 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.008B | 14.38 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.294B | 28.60 |
| Penumbra (PEN) | United States | $9.735B | 95.36 |
| Masimo (MASI) | United States | $9.336B | 45.18 |
| Teleflex (TFX) | United States | $8.528B | 13.60 |
| Glaukos (GKOS) | United States | $7.879B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.728B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.717B | 26.73 |
| Inari Medical (NARI) | United States | $3.408B | 0.00 |
| Veracyte (VCYT) | United States | $3.372B | 101.19 |
| LivaNova (LIVN) | United Kingdom | $2.796B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.337B | 17.75 |
| Tandem Diabetes Care (TNDM) | United States | $2.267B | 0.00 |
| TransMedics (TMDX) | United States | $2.261B | 71.66 |
| Elekta AB (EKTAY) | Sweden | $2.229B | 20.04 |
| Integra LifeSciences Holdings (IART) | United States | $1.864B | 9.74 |
| RxSight (RXST) | United States | $1.515B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.254B | 83.11 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.062B | 0.00 |
| Paragon 28 (FNA) | United States | $0.874B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.708B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 16.49 |
| IRadimed (IRMD) | United States | $0.699B | 37.80 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.558B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 31.48 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.453B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.440B | 23.83 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.331B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.230B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Nevro (NVRO) | United States | $0.162B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.12 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.011B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |